𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interaction of a monoclonal antibody against hEGF with a receptor site for EGF

✍ Scribed by Sonia Valente; Beatriz Souto; Henia Balter; Mick M Welling; Estela Román; Ana Robles; Ernest K.J Pauwels

Book ID
117688411
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
260 KB
Volume
26
Category
Article
ISSN
0969-8051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of ABX-EGF, a fully human an
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
✍ Xiao-Dong Yang; Xiao-Chi Jia; Jose R.F. Corvalan; Ping Wang; C.Geoffrey Davis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Overexpression of epidermal growth factor receptor (EGFr) has been demonstrated on many human tumors, and the increase in receptor expression levels has been linked with a poor clinical prognosis. Blocking the interaction of EGFr and the growth factors could lead to the arrest of tumor growth and po

Specific targeting of a mutant, activate
Specific targeting of a mutant, activated egf receptor found in glioblastoma using a monoclonal antibody
✍ David Hills; Gail Rowlinson-Busza; William J. Gullick 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 942 KB

## Abstract A truncated epidermal growth factor receptor (EGFR) expressed from a rearranged and amplified EGFR gene is present at high frequency in gliomas. In this work we show that when this receptor is expressed in NIH3T3 fibroblasts it is partially activated and confers tumorigenicity to this c

A new monoclonal antibody for detection
A new monoclonal antibody for detection of EGF-receptors in western blots and paraffin-embedded tissue sections
✍ A. Fernandez; E. Spitzer; R. Perez; F.-D. Boehmer; K. Eckert; W. Zschiesche; Pro 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 915 KB

The prognostic significance of the epidermal growth factor receptor status (EGF-R-status) for certain human tumors requires the development of antibodies useful for clinical application. We used purified receptor preparations to generate monoclonal antibodies immunoreactive with the EGF-R purified f